
Structural basis for the inhibition of AKR1B10 by the C3 brominated TTNPB derivative UVI2008
Keywords: Cancer; Enzyme inhibitor; Psoriasis; RAR/RXR agonist; Retinoic acid; Skin disease; AR; Aldose Reductase; AKR; Aldo-Keto Reductase; AKR1B10; AKR family member 1B10; AKR1B15; AKR family member 1B15; AKR1A1; AKR family member 1A1 or aldehyde reductase; ARIs;